Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia in males is linked to significant psychological distress, highlighting the need for both mental and dermatological care.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

The unit area trichogram is a reliable method to assess hair loss and treatment response in people with androgenic alopecia by measuring hair density and thickness.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

Androgens significantly affect female hair loss, and hormonal treatments may help.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Finasteride side effects in young men may be linked to specific gene variations.

Non-obese women with hair loss have higher heart disease risk.

Lower zinc levels may predict less effective hair loss treatment.

Medications for PCOS don't seem to raise heart disease risk.

New oral treatment, finasteride, effectively and safely treats common hair loss.

Women with hair loss have higher heart disease risk and unhealthy cholesterol levels.

Liver disease is linked to hair loss, especially in women and those with unhealthy lifestyles.

Individualized treatment improves symptoms and quality of life for women with PCOS.

PCOS and lifestyle choices like diet and hair removal methods play a key role in moderate hirsutism.

PRP combined with minoxidil is the most effective treatment for hair growth in androgenetic alopecia.

Men with androgenetic alopecia may have a higher risk of metabolic syndrome.

Increased cell death and reduced cell growth in hair follicles contribute to baldness.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

Testosterone affects androgen receptors and lipid storage in cells, while DHEA does not convert to testosterone or affect these receptors in the same way.

The patient with total hair loss did not regrow hair despite treatment, indicating a poor outlook for this type of hair loss.

Hair loss can indicate brain aging and potential small vessel disease, but more research is needed to understand the clinical impact.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Hair loss in young men linked to higher risk of insulin resistance and metabolic issues.